Patents Assigned to CENTRE NATIONAL DE LUTTE CONTRE LE CANCER
  • Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II
    Patent number: 9637544
    Abstract: Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: May 2, 2017
    Assignees: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, UNIVERSITE MONTPELLIER I, CENTRE NATIONAL DE LUTTE CONTRE LE CANCER, I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Christian Behrens, Isabelle Navarro-Teulon
  • Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II
    Patent number: 9012607
    Abstract: Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: April 21, 2015
    Assignees: Laboratoire Francais du Fractionnement et des Biotechnologies, Universite Montpellier I, Centre National de Lutte Contre le Cancer, I.N.S.E.R.M. (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Christian Behrens, Isabelle Navarro-Teulon
  • NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIBODY WHICH BINDS THE HUMAN ANTI-MULLERIAN HORMONE RECEPTOR TYPE II
    Publication number: 20150004156
    Abstract: The invention relates to novel pharmaceutical compositions including, as active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II) and an anticancer agent, as well as the therapeutic applications of these compositions.
    Type: Application
    Filed: December 21, 2012
    Publication date: January 1, 2015
    Applicants: LABORATOIRES FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, CENTRE NATIONAL DE LUTTE CONTRE LE CANCER, I.N.S.E.R.M. (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE MONTPELLIER 1
    Inventors: Christine Gaucher, Isabelle Navarro-Teulon
  • NOVEL MUTATED HUMANIZED 12G4 ANTIBODIES AND THE FRAGMENTS THEREOF AGAINST THE HUMAN ANTI-MULLERIAN HORMONE RECEPTOR TYPE II
    Publication number: 20130136743
    Abstract: Novel mutated humanized 12G4 antibodies, and fragments thereof, directed against the anti-Müllerian hormone type II receptor.
    Type: Application
    Filed: April 1, 2011
    Publication date: May 30, 2013
    Applicants: LFB BIOTECHNOLOGIES, I.N.S.E.R.M. (Institut National de la Sante et de Recherche Medicale), CENTRE NATIONAL DE LUTTE CONTRE LE CANCER, UNIVERSITE MONTPELLIER I
    Inventors: Christian Behrens, Isabelle Navarro-Teulon